CRA was retained by the claimant in a JAMS arbitration regarding a breach of contract dispute in connection with an oncology product. CRA’s team assisted counsel in calculating the revenue and profit associated with the product at issue and the portion paid to the claimant. The results of these analyses assisted counsel in settling the dispute prior to a hearing.
2024 International Arbitration review: Updates and trends
Dear Clients and Friends, Our activities in 2024 reflected ongoing trends from 2023 and emerging forces affecting the landscape for investors and companies...